free性video西欧极品,伊人依成久久人综合网,中文字幕人妻一区二区三区熟女,男女高潮激烈无遮挡免费观软件 ,成人3d动漫一区二区三区

  • Farxiga Meets Primary Endpoint in Heart Failure Trial americanpharmaceuticalreview
    August 21, 2019
    AstraZeneca has announced positive results from the landmark Phase III DAPA-HF trial which showed that?Farxiga?(dapagliflozin) met the primary composite endpoint with a statistically-significant and clinically-meaningful reduction of ...
  • Entresto tops mainstay ACE inhibitor in heart failure trial pharmaphorum
    December 04, 2018
    Two years ago, Novartis launched a big trials programme for its heart failure drug Entresto in the hope of revving up disappointing initial sales, and one of those trials has just delivered positive results.

Contact Us

PharmaSources@imsinoexpo.com

Tel: (+86) 400 610 1188

WhatsApp/Telegram/Wechat: +86 13621645194
+86 15021993094

PharmaSources Customer Service